Volume | 1,129,964 |
|
|||||
News | - | ||||||
Day High | 76.97 | Low High |
|||||
Day Low | 75.39 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Hologic Inc | HOLX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
76.76 | 75.39 | 76.97 | 75.721 | 76.71 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
20,421 | 1,129,964 | $ 75.81 | $ 85,664,006 | - | 64.02 - 87.88 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:03:26 | 1 | $ 74.95 | USD |
Hologic (HOLX) Options Flow Summary
Hologic Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
17.77B | 234.73M | - | 4.05B | 456M | 1.94 | 38.98 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Hologic News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HOLX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 74.97 | 77.81 | 74.53 | 76.10 | 1,389,613 | 0.74 | 0.99% |
1 Month | 77.47 | 79.22 | 74.53 | 76.84 | 1,552,978 | -1.76 | -2.27% |
3 Months | 74.45 | 79.22 | 71.25 | 75.32 | 1,781,432 | 1.26 | 1.69% |
6 Months | 67.67 | 79.22 | 64.02 | 72.90 | 1,826,918 | 8.04 | 11.88% |
1 Year | 84.88 | 87.88 | 64.02 | 74.66 | 1,742,347 | -9.17 | -10.80% |
3 Years | 73.31 | 87.88 | 59.78 | 73.16 | 1,749,852 | 2.40 | 3.27% |
5 Years | 44.51 | 87.88 | 26.49 | 65.54 | 1,901,241 | 31.20 | 70.10% |
Hologic Description
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |